Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta Blockers and Fracture Risk in Osteoporosis
NCT04704947Phase 3Recruiting
- Start
- Oct 2017
- Primary completion
- Oct 2030
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of propranolol, bisoprolol in osteoporosis. Started Oct 2017; status: recruiting.
02
Drugs
propranololbisoprolol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT04704947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04704947.